Roles of p63 in regulation of miRNA and LincRNA targets in metastatic cancer

p63 在转移性癌症中 miRNA 和 LincRNA 靶标调节中的作用

基本信息

  • 批准号:
    8461599
  • 负责人:
  • 金额:
    $ 45.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-05-01 至 2017-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Mortality in cancer is most often due to the development of distant metastases for which almost no effective systemic treatments exist. The study of genes relevant for the regulation of metastasis in vivo is therefore of great importance. The functions of p63, a p53 family member, are beginning to be understood in contexts in which p53 function has been well established, including apoptosis and tumor suppression (Su et al., Nature 2010) as well as in other roles such as metastasis (Su et al., Nature 2010), skin development, and stem cell maintenance (Su et al., Cell Stem Cell 2009). The complexity of p63 function is due in part to the existence of multiple isoforms that previously could not be studied independently. Full length TA isoforms of p63 contain a transactivation domain, structurally and functionally resembling p53, whereas the ?N isoforms of p63, while also possessing transactivation activity, antagonize the activities of p53 and the TA isoforms of p63 and p73, the other p53 family member. Interestingly, mutant p53, present in a wide variety of human cancers, has been shown to interact with p63 isoforms and inactivate their function. By generating and studying mice with isoform-specific null alleles of p63, the TAp63-/- and ?Np63-/- mice, we have shown that these genes have distinct roles in suppression of tumorigenesis and metastasis. TAp63-/- mice are highly susceptible to spontaneous metastatic tumors, and TAp63 potently suppresses tumor metastasis by direct coordinate transcriptional regulation of Dicer and several miRNAs (Su et al., Nature 2010). In addition, we have extended these findings to multiple human tumor types including squamous cell carcinoma, lung adenocarcinoma, and breast adenocarcinoma, indicating this function of TAp63 is widely important. We have also shown that ?Np63 can suppress invasion and transcriptionally regulates DGCR8, another critically important enzyme necessary for miRNA processing. We hypothesize that TAp63 and ?Np63 regulate distinct miRNAs in different cellular compartments to suppress tumorigenesis and metastasis and to engage the DNA damage response. We will address our hypothesis by proposing the following specific aims: Specific Aim 1: To understand the mechanistic regulation of miRNA and LincRNA targets by p63 isoforms in the cell of origin of carcinomas (epidermal cells). Specific Aim 2: To understand the mechanistic regulation of miRNAs and LincRNAs by p63 isoforms in stem cells of skin cancer and metastasis. Specific Aim 3: To understand the roles of miRNAs and LincRNAs regulated by p63 isoforms in the DNA damage response and p53 compensation.
描述(由申请人提供):癌症的死亡率通常是由于远处转移的发展,对此几乎没有有效的全身治疗。因此,研究与体内转移调控相关的基因具有重要意义。p53家族成员p63的功能开始在p53功能已经很好建立的背景下被理解,包括细胞凋亡和肿瘤抑制(Su et al.,Nature 2010)以及其他作用如转移(Su et al.,Nature 2010)、皮肤发育和干细胞维持(Su et al. Cell Stem Cell 2009)。p63功能的复杂性部分是由于以前无法独立研究的多种亚型的存在。全长TA异构体的p63含有一个反式激活结构域,结构和功能类似p53,而?p63的N亚型,同时也具有反式激活活性,拮抗p53和p63和p73的TA亚型的活性,p53家族的另一个成员。有趣的是,存在于多种人类癌症中的突变型p53已被证明与p63亚型相互作用并破坏其功能。 通过产生和研究小鼠的亚型特异性无效等位基因的p63,TAp 63-/-和?Np 63-/-小鼠中,我们已经表明这些基因在抑制肿瘤发生和转移中具有不同的作用。TAp 63-/-小鼠对自发转移性肿瘤高度易感,并且TAp 63通过Dicer和几种miRNA的直接协同转录调节而有效地抑制肿瘤转移(Su et al.,Nature 2010)。此外,我们已经将这些发现扩展到多种人类肿瘤类型,包括鳞状细胞癌,肺腺癌和乳腺癌,表明TAp 63的这种功能非常重要。我们也证明了这一点。Np 63可以抑制入侵并转录调节DGCR 8,这是miRNA加工所必需的另一种至关重要的酶。我们假设TAp 63和?Np 63在不同的细胞区室中调节不同的miRNA,以抑制肿瘤发生和转移,并参与DNA损伤反应。我们将通过提出以下具体目标来解决我们的假设:具体目标1:了解癌起源细胞(表皮细胞)中p63亚型对miRNA和LincRNA靶标的机制调节。具体目标2:了解皮肤癌干细胞和转移灶中p63亚型对miRNAs和LincRNAs的调控机制。具体目标3:了解p63亚型调控的miRNAs和LincRNAs在DNA损伤反应和p53补偿中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elsa R Flores其他文献

Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings.
唾液腺肿瘤发生中 ΔN 和 TAp63 亚型的表达和调节临床和实验结果。
  • DOI:
    10.1016/j.ajpath.2011.03.037
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Y. Mitani;Jie Li;Randal S. Weber;Scott L Lippman;Elsa R Flores;C. Caulin;Adel K. El
  • 通讯作者:
    Adel K. El

Elsa R Flores的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elsa R Flores', 18)}}的其他基金

Project 1
项目1
  • 批准号:
    10171099
  • 财政年份:
    2021
  • 资助金额:
    $ 45.74万
  • 项目类别:
Project 1
项目1
  • 批准号:
    10438713
  • 财政年份:
    2021
  • 资助金额:
    $ 45.74万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10438717
  • 财政年份:
    2021
  • 资助金额:
    $ 45.74万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10171103
  • 财政年份:
    2021
  • 资助金额:
    $ 45.74万
  • 项目类别:
Identifying Metabolic Vulnerabilities in Lung Cancer
识别肺癌的代谢脆弱性
  • 批准号:
    10438711
  • 财政年份:
    2021
  • 资助金额:
    $ 45.74万
  • 项目类别:
Identifying Metabolic Vulnerabilities in Lung Cancer
识别肺癌的代谢脆弱性
  • 批准号:
    10171098
  • 财政年份:
    2021
  • 资助金额:
    $ 45.74万
  • 项目类别:
Project 1
项目1
  • 批准号:
    10676731
  • 财政年份:
    2021
  • 资助金额:
    $ 45.74万
  • 项目类别:
Identifying Metabolic Vulnerabilities in Lung Cancer
识别肺癌的代谢脆弱性
  • 批准号:
    10676730
  • 财政年份:
    2021
  • 资助金额:
    $ 45.74万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10676745
  • 财政年份:
    2021
  • 资助金额:
    $ 45.74万
  • 项目类别:
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
鉴定非编码 RNA 以治疗转移性肺腺癌和鳞状细胞癌中不可成药的途径
  • 批准号:
    9903249
  • 财政年份:
    2016
  • 资助金额:
    $ 45.74万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 45.74万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 45.74万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 45.74万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 45.74万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 45.74万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 45.74万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 45.74万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 45.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 45.74万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 45.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了